FDA rejects Merck's insomnia drug

(Reuters) - Merck & Co Inc said the U.S. Food and Drug Administration rejected the company's experimental insomnia drug, citing safety issues.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/tK9upHnK8vo/story01.htm

accredited phlebotomy schools medical assistant training phlebotomy schools in massachusetts